ANNEXSupplementary provisions
ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order: Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Porcine prolactin NOT APPLICABLE Porcine No MRL required NOT APPLICABLE For oral use in newborn piglets at a dose of up to 0,2 mg/animal. For use in sows at a total dose of up to 5 mg/animal. Agents acting on the reproductive system’